glp-1 drugs moa Mechanisms of Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation GLP-1 and Anesthesia: Considerations and

16561664, Oct

Wu C-S, Lai M-S, Gau SS-F, Wang S-C, Tsai H-J (2014) Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan

This protective association has been repeatedly observed, linking GLP-1RA use to lower risks of POAG, ocular hypertension, and the need for first-line glaucoma treatment in large cohorts of T2DM patients [105107]

Thats where a new wave of oral GLP-1 medications could make a difference

A recent study demonstrated that GLP-1 has a neurotrophic effect and promotes neurotrophic processes in the brain (Mainardi et al., 2015)

Realworld clinical outcomes and predictors of glycaemic and weight response to exenatide once weekly in patients with type 2 diabetes: the CIBELES project